After Myriad, what makes a gene patent claim 'markedly different' from nature?
Accepted version
Peer-reviewed
Repository URI
Repository DOI
Change log
Authors
Aboy, Mateo
Liddicoat, Johnathon
Liddell, Kathleen
Jordan, Matthew
Crespo, Cristina
Abstract
Examining the types of claim amendments that have transformed isolated gene claims from patent-ineligible into eligible subject matter provides clarity into the threshold of eligibility for gene-related patents.
Description
Keywords
48 Law and Legal Studies, 4806 Private Law and Civil Obligations, Genetics
Journal Title
Nat Biotechnol
Conference Name
Journal ISSN
1087-0156
1546-1696
1546-1696
Volume Title
35
Publisher
Springer Science and Business Media LLC
Publisher DOI
Rights
All rights reserved